SBC

SBC Medical Group

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 100%
Negative

Neutral
GlobeNewsWire
3 days ago
SBC Medical to Announce 1Q 2026 Financial Results
IRVINE, Calif., May 01, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced it will release its financial results for the first quarter ended March 31, 2026, before U.S. market open on May 14, 2026.
SBC Medical to Announce 1Q 2026 Financial Results
Neutral
GlobeNewsWire
7 days ago
SBC Medical Announces Full-Scale Rollout of Aesthetic Healthcare-Focused Interpretation App "Talk Bridge" Across All Shonan Beauty Clinic Locations
IRVINE, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) ("SBC Medical" or the "Company"), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced a comprehensive initiative to enhance English-speaking inbound customer support at Shonan Beauty Clinic.
SBC Medical Announces Full-Scale Rollout of Aesthetic Healthcare-Focused Interpretation App "Talk Bridge" Across All Shonan Beauty Clinic Locations
Neutral
Accesswire
12 days ago
Emerging Growth Research Releases Flash Report on SBC Medical Group; Reiterates Buy-Extended Rating and $9.00 Price Target
NEW YORK CITY, NY / ACCESS Newswire / April 22, 2026 / Emerging Growth Research today announced the release of a Flash Report on SBC Medical Group Holdings, Inc. (NASDAQ:SBC), reiterating its Buy-Extended rating and maintaining its 12-month price target of $9.00, representing potential upside from the Company's recent share price of $3.65 as of April 21, 2026. The Flash Report provides an update following recent share price volatility tied to a secondary share transaction, while reaffirming the Company's long-term growth outlook and underlying fundamentals.
Emerging Growth Research Releases Flash Report on SBC Medical Group; Reiterates Buy-Extended Rating and $9.00 Price Target
Neutral
Business Wire
13 days ago
SBC Medical Announces Closing of Previously Announced Secondary Public Offering of 3.1 million shares of Common Stock
IRVINE, Calif.--(BUSINESS WIRE)-- #Healthcare--SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“the Company”), a Management Service Organization operating a wide range of franchise businesses across diverse medical fields, today announced the closing of its previously announced underwritten secondary public offering of 3,100,000 shares of the Company's common stock by Dr. Yoshiyuki Aikawa (the “Selling Stockholder”) at the public offering price of $3.25 per share. The proceeds from the offering to the.
SBC Medical Announces Closing of Previously Announced Secondary Public Offering of 3.1 million shares of Common Stock
Neutral
Business Wire
15 days ago
SBC Medical Announces Pricing of Secondary Public Offering of 3.1 Million Shares of Common Stock
IRVINE, Calif.--(BUSINESS WIRE)-- #Healthcare--SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“the Company”), a Management Service Organization operating a wide range of franchise businesses across diverse medical fields, today announced the pricing of the underwritten secondary public offering of 3,100,000 shares of the Company's common stock by Dr. Yoshiyuki Aikawa (the “Selling Stockholder”) at the public offering price of $3.25 per share. Additionally, the Selling Stockholder has granted the unde.
SBC Medical Announces Pricing of Secondary Public Offering of 3.1 Million Shares of Common Stock
Neutral
Accesswire
28 days ago
Emerging Growth Research Reiterates Buy-Extended Rating on SBC Medical Group Holdings, Inc. with $9.00 Price Target Following Q4:25 Quarterly Update
NEW YORK CITY, NY / ACCESS Newswire / April 6, 2026 / Emerging Growth Research today announced the release of its Quarterly Update Report on SBC Medical Group Holdings, Inc. (Nasdaq:SBC), reiterating a Buy-Extended rating and maintaining its 12-month price target of $9.00, representing potential upside from the Company's closing price of $4.47 on April 3, 2026. The Quarterly Update reflects SBC's Q4:25 financial results, ongoing business transition, and outlook for a return to revenue growth in 2026 following pricing-related headwinds experienced during 2025.
Emerging Growth Research Reiterates Buy-Extended Rating on SBC Medical Group Holdings, Inc. with $9.00 Price Target Following Q4:25 Quarterly Update
Neutral
MCAP MediaWire
1 month ago
PRISM MarketView Features Exclusive Q&A with SBC Medical CEO Yoshiyuki Aikawa on Growth Strategy, U.S. Expansion, and Improving Unit Economics
NEW YORK, March 31, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – PRISM MarketView today published an exclusive Q&A feature with Yoshiyuki Aikawa, Chairman and Chief Executive Officer of SBC Medical Group Holdings (Nasdaq: SBC), a Japan-based management services organization building a large and growing global aesthetic medical network.
PRISM MarketView Features Exclusive Q&A with SBC Medical CEO Yoshiyuki Aikawa on Growth Strategy, U.S. Expansion, and Improving Unit Economics
Neutral
GlobeNewsWire
1 month ago
PRISM MarketView Features Exclusive Q&A with SBC Medical CEO Yoshiyuki Aikawa on Growth Strategy, U.S. Expansion, and Improving Unit Economics
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- PRISM MarketView today published an exclusive Q&A feature with Yoshiyuki Aikawa, Chairman and Chief Executive Officer of SBC Medical Group Holdings (Nasdaq: SBC), a Japan-based management services organization building a large and growing global aesthetic medical network. In the interview, Aikawa discusses SBC Medical's evolution from a domestic platform into a globally scalable model, as well as the company's recent operational inflection, U.S. market entry, and long-term growth strategy.
PRISM MarketView Features Exclusive Q&A with SBC Medical CEO Yoshiyuki Aikawa on Growth Strategy, U.S. Expansion, and Improving Unit Economics
Neutral
Business Wire
1 month ago
SBC Medical Announces Fourth Quarter and Full Year 2025 Financial Results
IRVINE, Calif.--(BUSINESS WIRE)-- #Healthcare--SBC announced its financial results for the full fiscal year 2025 (twelve months ended December 31, 2025).
SBC Medical Announces Fourth Quarter and Full Year 2025 Financial Results
Neutral
Business Wire
1 month ago
SBC Medical Announces Next-Generation Wellness Strategy “SBC Wellness 2.0”
IRVINE, Calif.--(BUSINESS WIRE)--SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced “SBC Wellness 2.0,” a new wellness and longevity platform that combines aesthetic healthcare, preventative care, and data-driven health management. The initiative positions SBC Medical to participate in the fast-growing longevity market, which is pr.
SBC Medical Announces Next-Generation Wellness Strategy “SBC Wellness 2.0”